Pharmafile Logo
Pharmafocus logo
Advanced Search

patents

Showing 15 posts of 35 posts found.

Coins

ANALYSIS: The challenges of forecasting biosimilar sales across Europe

October 29, 2015
Manufacturing and Production, Research and Development, Sales and Marketing biologics, biosimilars, generics, patent cliff, patents, sales, sales forecasts

The introduction of biologic medicines revolutionised treatment in several key therapeutic areas, including oncology, diabetes and various inflammatory diseases.The landscape …

Feature
BGMA D-G Warwick Smith

OPINION: ‘More work remains if biosimilars are to fulfil their potential’

October 27, 2015
Manufacturing and Production, Research and Development, Sales and Marketing British Generic Manufacturers Association, NHS, bgma, biosimilars, generics, patent cliff, patents

Despite having a mature generics market which fulfils more than three-quarters of all prescriptions in the UK, and as a …

Feature
Humira

Future Focus: The industry’s top five biggest drug patent expirations in 2016

October 21, 2015
Manufacturing and Production, Research and Development biosimilars, blockbuster, generics, patent cliff, patents

From Humira to Cubicin, some multi-billion dollar drugs are set to be hit hard by patent expiries next year, and …

Feature
Daiichi Sankyo

Daiichi sheds more US jobs as generic losses take their toll

October 20, 2015
Daiichi, Daiichi Sankyo, generic competition, generics, job losses, patent cliff, patents, redundancies

The Japan-based drugmaker Daiichi Sankyo is to cut up to 1,200 jobs – or about half its workforce – in …

News
BIS

UK second in global innovation index

September 18, 2015
Medical Communications, Research and Development Global Innovation Index, World Intellectual Property Organisation, innovation, intellectual property, patents, wipo

The UK – along with Switzerland, Sweden, the Netherlands and the US – is in the world’s five most innovative …

News

Lundbeck sheds 1,000 jobs in £284 million restructure

August 20, 2015
Manufacturing and Production, Sales and Marketing Lundbeck, generics, job losses, patents, redundancies, restructure, restructuring

Lundbeck is cutting a thousand jobs globally as part of a restructuring programme to significantly lower its cost and focus …

News
Pfizer image

Pfizer offers to pay for UK Lyrica switches

August 13, 2015
Lyrica, NHS England, Pfizer, generics, neuropathic pain, patents, pregabalin

Pfizer is to pay the administrative costs of GPs to switch patients to Lyrica from generic versions of pregabalin, as …

News
pillsphotos1

The Pharmafocus debate: Is the price of new hepatitis C treatments fair?

April 27, 2015
Research and Development, Sales and Marketing Doctors of the World, Drug pricing, EFPIA, Gilead, MSF, drug cost, hepatitis C, patents, sofosbuvir, sovaldi

YES – says Richard Bergström, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), who argues that …

Feature
GSK image

GSK settles cancer patent dispute

March 28, 2012
Research and Development, Sales and Marketing GSK, Genmab, Roche, ofatumumab, patents

GlaxoSmithKline has settled a long-running patent dispute over its cancer treatment ofatumumab.  The US patents, which relate to recombinant antibody …

News

India’s Nexavar patent ruling disturbs pharma

March 12, 2012
Sales and Marketing India, emerging markets, intellectual property, patents

India is to allow Bayer’s cancer treatment Nexavar to be subject to a compulsory licence, allowing a generic firm to …

News
Novartis image

Novartis Indian patent battle nears conclusion

March 7, 2012
Sales and Marketing Glivec, HIV, India, Novartis, patents

A long-running battle over the patent of cancer treatment Glivec in India is about to reach its dramatic climax.India’s Supreme …

News

Pharma unprepared for annus horribilis

January 12, 2012
Research and Development, Sales and Marketing AZ, Pfizer, Takeda, patents, pharma

A new survey shows pharma is not prepared to deal with the tough year ahead as many blockbuster drugs begin …

News

European judge rules against stem cell patents

October 19, 2011
Research and Development Stem cells, patents

The European Court of Justice has ruled that stem cells cannot be patented, representing a major blow to research in …

News

European scrutiny of pharma patent deals to continue

July 6, 2010
Sales and Marketing European Commission, competition, patents

Europe’s drug watchdog has served notice that it will keep up scrutiny of pharma patent settlements to ensure they are …

News

India revokes Roche’s Valcyte patent

May 19, 2010
Sales and Marketing India, Roche, patents

Indian authorities have revoked a patent granted in 2007 for Roche’s brand Valcyte, saying it had been wrongly granted.The decision was welcomed …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026